MyoKardia, Inc. IPO Research Information

MyoKardia, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on MyoKardia, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
MyoKardia, Inc.	MYOK - NASDAQ	$15.00-$17.00	$10.00	$11.08	5.4 million	10/29/2015
Underwriter(s): Credit Suisse, Cowen & Co.
Co-Manager(s): Wells Fargo Securities, Wedbush PacGrow
Industry: Health Care
Filing(s): Filed 2015-09-28 Underwriters Changed 2015-10-13 Terms Added 2015-10-19

MyoKardia, Inc. Quote & Chart - Click for current quote - MYOK

About MyoKardia, Inc. (adapted from MyoKardia, Inc. prospectus):
They are a clinical stage biopharmaceutical company pioneering a precision medicine approach to discover, develop and commercialize targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "MYOK" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.